Real‐World Dosing and Persistence of Oral Treprostinil Initiation Strategies in Patients With Pulmonary Arterial Hypertension

Documenti analoghi

• Heart Rate Variability in Pulmonary Arterial Hypertension
  di: Bishal Gyawali, et al.
  Pubblicazione: (2025)
• Supplemental Oxygen Decreases Cardiac Effort in Pulmonary Arterial Hypertension
  di: Kyle Norton, et al.
  Pubblicazione: (2026)
• Real‐World Comparison of Patients With PH‐ILD Initiating Inhaled Treprostinil Versus Patients Who Remain Untreated
  di: Steven J. Cassady, et al.
  Pubblicazione: (2025)
• Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
  di: Marshaleen Henriques King, et al.
  Pubblicazione: (2025)
• Comorbidities and Events of Clinical Interest in Patients with Pulmonary Arterial Hypertension (PAH): Analysis of Real‐World Data
  di: Julia R. DiBello, et al.
  Pubblicazione: (2026)